Panagora Asset Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Sell
96,574
-33,743
-26% -$322K ﹤0.01% 763
2026
Q1
$1.19M Sell
130,317
-47,747
-27% -$400K ﹤0.01% 677
2025
Q4
$1.32M Sell
178,064
-147,135
-45% -$1.06M ﹤0.01% 643
2025
Q3
$2.18M Sell
325,199
-1,625
-0.5% -$11.3K 0.01% 511
2025
Q2
$2.16M Buy
326,824
+48,519
+17% +$344K 0.01% 459
2025
Q1
$2.55M Buy
278,305
+25,888
+10% +$259K 0.01% 464
2024
Q4
$2.65M Buy
252,417
+17,109
+7% +$202K 0.01% 458
2024
Q3
$2.81M Buy
235,308
+98,459
+72% +$851K 0.01% 471
2024
Q2
$787K Buy
+136,849
New +$751K ﹤0.01% 795

Other funds holding BVS

Panagora Asset Management's BVS Position: Q2 2026 in Review

Panagora Asset Management reduced its Bioventus (BVS) stake by 26% in Q2 2026, selling an estimated $322K and leaving 96,574 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Panagora Asset Management first reported a position in BVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.81M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Panagora Asset Management held 96,574 shares of Bioventus worth $912K as of Q2 2026.
  • Panagora Asset Management sold 33,743 Bioventus shares in Q2 2026, an estimated $322K.
  • Bioventus made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #763 holding.
  • Panagora Asset Management first reported a position in Bioventus in Q2 2024 and has held it in 9 quarters since.
  • Panagora Asset Management's Bioventus position peaked at $2.81M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.